These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33469596)

  • 21. High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
    Guartazaca-Guerrero S; Rodríguez-Morales J; Rizo-Téllez SA; Solleiro-Villavicencio H; Hernández-Valencia AF; Carrillo-Ruiz JD; Escobedo G; Méndez-García LA
    Exp Neurobiol; 2021 Jun; 30(3):256-261. PubMed ID: 34230225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivity.
    Kumar NP; Balaji S; Devi PG; Ramraj B; Nancy A; Selvaraj N; Ahamed SF; M K; S S; Gunasundari A; Seetha A; Varadarajan P; S E; Venkataraman A; Babu S
    J Infect; 2024 Dec; 89(6):106314. PubMed ID: 39426633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
    Shibabaw T
    J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F
    J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.
    Pranzatelli MR; Tate ED; McGee NR; Verhulst SJ
    J Neuroimmunol; 2014 Jan; 266(1-2):75-81. PubMed ID: 24342231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.
    Al Saiegh F; Ghosh R; Leibold A; Avery MB; Schmidt RF; Theofanis T; Mouchtouris N; Philipp L; Peiper SC; Wang ZX; Rincon F; Tjoumakaris SI; Jabbour P; Rosenwasser RH; Gooch MR
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):846-848. PubMed ID: 32354770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.
    Fong D; San Nicolò KO; Alber M; Mitterer M
    Wien Klin Wochenschr; 2021 Apr; 133(7-8):359-363. PubMed ID: 33502609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series.
    Lauridsen KH; Olsen KB; Lund EL; Jensen TO; Pedersen TI; Harboe ZB; Antsupova V; Rasmussen LD; Röser D; Banner J; Franck KT; Vorobieva Solholm Jensen V
    Clin Pathol; 2022; 15():2632010X221139096. PubMed ID: 36448025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    medRxiv; 2020 Aug; ():. PubMed ID: 32869036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated cerebrospinal fluid interleukin-17A and interferon-γ levels in early asymptomatic neurosyphilis.
    Pastuszczak M; Jakiela B; Wielowieyska-Szybinska D; Jaworek AK; Zeman J; Wojas-Pelc A
    Sex Transm Dis; 2013 Oct; 40(10):808-12. PubMed ID: 24275734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.